Drawing for Serial No. 86923933

USPTO serial 86923933

Serial No. 86923933

Reviewed by CopyMark Law Group

Status 606
Filing date
Status date
Registration date
Examiner
EVANKO, PATRICIA MALESARDI
Law office
INTENT TO USE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with Serial No. 86923933?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Goods and services

ClassDescriptionStatusFirst use
009Downloadable software in the nature of a mobile application for handheld computers, mobile computer devices, mobile phones, media players, that provides access to information, advice and calculation tools in the fields of healthcare, medicine, medical treatment and patient care; computer software for controlling and managing patient medical information; computer programs for controlling and managing patient medical information; computer programs for use in the field of healthcare for the collection, maintenance and management of data for patient records, clinical diagnosis and assessment, patient treatment, goals management, outcome analysis, and clinical records; computer software for use by healthcare providers to analyze the outcomes of medical procedures and information relating to patient care; computer software for use in database management; computer database management software for clinical use, for clinical governance, clinical audit, collecting and analyzing information relating to patient demographics, procedures and outcomes; downloadable electronic publications in the nature of questionnaires on the subject of healthcare, medicine, medical treatment and patient care; downloadable electronic publications in the nature of patient reported outcome questionnaires on the subject of healthcare, medicine, medical treatment and patient care for use with a telecommunications device; computer software for enabling the user to utilise the camera facility on a mobile phone, handheld computer or other mobile device or computer to track symptoms; electronic computer databases featuring information about medical education in the fields of healthcare, medicine, medical treatment and patient care recorded on computer mediaACTIVE
041Education, namely, providing on-line instruction in the fields of healthcare, the use of pharmaceuticals, medical research, medical science, medicine and related treatments; providing online databases featuring education information about medical education in the fields of healthcare, medicine, medical treatment and patient care; educational services, namely, development of multi-media educational content for use with mobile devices and computers, namely, a series of health-related questions for response from the user that result in a report that provides health-related information in the form of recommended educational resources and treatment information in relation to the treatment of envenomation by snakes; training in the use and operation of pharmaceutical products, pharmaceutical preparations and consultation relating thereto; educational services, namely, conducting live and online seminars, classes, workshops, conferences, lectures, panel discussions, and training programs in the fields of healthcare, the use of pharmaceutical, medical research, medicine and related treatments; educational services, namely, providing non-downloadable webinars in the fields of healthcare, the use of pharmaceuticals, medical research, medicine, and related treatments; educational services, namely, conducting live and online seminars, classes, workshops, conferences, lectures, panel discussions and training in the fields of health; educational services, namely, providing non-downloadable webinars in the field of healthcare, the use of pharmaceuticals, medical research, medicine, and related treatments; education services, namely, conducting online and telephonic instruction and courses in the fields of healthcare, the use of pharmaceuticals, medical research, medicine, and related treatments; providing educational information and advice relating to education, training and education and training development provided online all relating to the treatment of envenomation by snakes; providing educational electronic online databases featuring information about medical education for medical purposes in the field of treatment of envenomation by snakesACTIVE
044Medical services; provision of medical information; provision of an on-line computer database featuring medical information; providing medical information via the Internet and by telecommunication means; healthcare services; providing medical information; medical services relating to the treatment of envenomation by snakes; providing a website featuring medical information in the fields of medicine, medical treatment, patient care, prescription drugs, pharmaceutical ordering, prescribing information and instructions, and dispensing practices of drugs, medical treatment and aftercare; medical services, namely, diagnosis, assessment, treatment and aftercare in the field of envenomation by snakes; medical services in the nature of analysis for the diagnosis and treatment of persons; pharmacy advice, namely, medical advice on pharmaceuticals; medical services for diagnosis in the fields of treatment of envenomation by snakes; medical health assessment services in the field of treatment of envenomation by snakes; medical treatment services in the field of treatment of envenomation by snakes; medical after care services in the field of treatment of envenomation by snakes; medical advisory services relating to health and healthcare; medical advisory services relating to medicine and medical treatment and services; medical advisory services relating to patient care; medical services for the purpose of patient diagnosis and treatment, namely, conducting health assessment surveys, health risk assessment surveys, treatment outcome surveys and health advice and health information services; health care consultancy services; consultancy services relating to medical treatment; information services relating to health care and medical treatment; providing health and medical information via telephonic hotline services, namely, providing medical records information to medical, medical counselling and nursing personnel to assist them with patient coverage, reimbursement, pharmaceutical ordering, and site-of-care medical support questions; provision of medical records by telephonic hotline services; healthcare consultancy services, namely, providing healthcare consulting via a telephonic hotline for medical, counselling and nursing personnel; healthcare consultancy services, namely, providing patient and patient medical record information by telephonic hotline services; providing health and medical information by telephonic hotline services; healthcare consultancy services; consultancy services relating to medical treatment; information services relating to healthcare and medical treatment; advisory services relating to medical treatment services; Medical services relating to treatment of snakebite envenomation; providing medical advisory, consultancy and information services relating to the aforesaid services; providing electronic online databases for medical purposes in the field of treatment of envenomation by snakesACTIVE

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (MAB6): The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.

DateCodeEventWhat it means
Oct 26, 2020MAB6ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Oct 26, 2020ABN6ABANDONMENT - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Aug 30, 2020CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Aug 30, 2020TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED
Aug 30, 2020EWORTEAS WITHDRAWAL AS DOMESTIC REPRESENTATIVE RECEIVED
Aug 30, 2020EWAFTEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Aug 30, 2020ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Aug 30, 2020REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Aug 30, 2020COARTEAS CHANGE OF OWNER ADDRESS RECEIVED
Mar 11, 2020EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Mar 10, 2020EX5GSOU EXTENSION 5 GRANTED
Mar 9, 2020AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL
Feb 27, 2020EXT5SOU EXTENSION 5 FILED
Feb 27, 2020EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Sep 11, 2019EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Sep 9, 2019EX4GSOU EXTENSION 4 GRANTED
Sep 9, 2019EXT4SOU EXTENSION 4 FILED
Sep 9, 2019EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Jul 8, 2019DOCKASSIGNED TO EXAMINER
Mar 13, 2019EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Mar 11, 2019EX3GSOU EXTENSION 3 GRANTED
Mar 11, 2019EXT3SOU EXTENSION 3 FILED
Mar 11, 2019EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Sep 21, 2018EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Sep 19, 2018EX2GSOU EXTENSION 2 GRANTED
Sep 19, 2018EXT2SOU EXTENSION 2 FILED
Sep 19, 2018EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Mar 16, 2018EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Mar 14, 2018EX1GSOU EXTENSION 1 GRANTED
Mar 14, 2018EXT1SOU EXTENSION 1 FILED
Mar 14, 2018EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Sep 19, 2017NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Jul 25, 2017NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jul 25, 2017PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jul 5, 2017NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jun 13, 2017CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER
Jun 13, 2017XAECEXAMINER'S AMENDMENT ENTERED
Jun 13, 2017GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Jun 13, 2017GNEAEXAMINERS AMENDMENT E-MAILED
Jun 13, 2017CNEAEXAMINERS AMENDMENT -WRITTEN
Apr 12, 2017RDX3NOTIFICATION FOR REQ FOR RECON DENIED NO APPEAL FILED
Apr 12, 2017RDX1ACTION FOR REQ FOR RECON DENIED NO APPEAL FILED E-MAILED
Apr 12, 2017RRDXACTION REQ FOR RECON DENIED NO APPEAL FILED COUNTED NOT MAILED
Mar 29, 2017TEMETEAS/EMAIL CORRESPONDENCE ENTERED
Mar 28, 2017CRFACORRESPONDENCE RECEIVED IN LAW OFFICE
Mar 28, 2017ERFRTEAS REQUEST FOR RECONSIDERATION RECEIVED
Dec 13, 2016GNFNNOTIFICATION OF FINAL REFUSAL EMAILED
Dec 13, 2016GNFRFINAL REFUSAL E-MAILEDA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Dec 13, 2016CNFRFINAL REFUSAL WRITTENA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Nov 29, 2016TEMETEAS/EMAIL CORRESPONDENCE ENTERED
Nov 28, 2016CRFACORRESPONDENCE RECEIVED IN LAW OFFICE
Nov 28, 2016TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jun 17, 2016GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jun 17, 2016GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jun 17, 2016CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jun 13, 2016DOCKASSIGNED TO EXAMINER
May 12, 2016AMPXPRELIMINARY/VOLUNTARY AMENDMENT - ENTERED
May 12, 2016ALIEASSIGNED TO LIE
Apr 28, 2016PARITEAS VOLUNTARY AMENDMENT RECEIVED
Mar 5, 2016MDSCNOTICE OF DESIGN SEARCH CODE E-MAILED
Mar 4, 2016NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Mar 3, 2016NWAPNEW APPLICATION ENTERED

Frequently asked questions

Related guidance